Treatment of concurrent etizolam and tianeptine withdrawal following accidental overdose

Author:

Markovic Marija1ORCID,Niwash Dania2ORCID

Affiliation:

1. 1 (Corresponding author) Clinical Pharmacy Specialist, Psychiatry, Hackensack University Medical Center, Hackensack, New Jersey, marija.markovic@hmhn.org

2. 2 Psychiatric Physician Assistant, Hackensack University Medical Center, Hackensack, New Jersey

Abstract

Abstract Background The availability of nonapproved psychoactive substances with addiction potential from internet sources poses a significant threat to public health. Polysubstance abuse or inadvertent contamination of preparations may result in clinically challenging intoxication and withdrawal syndromes. Case Report We report a case of a 32-year-old male with an approximate 2-year history of taking internet-obtained etizolam and tianeptine who presented to the hospital following an overdose. He experienced subsequent withdrawal symptoms consistent with benzodiazepine and opioid withdrawal. Initial attempts at managing symptoms with chlordiazepoxide 25 mg every 6 hours did not relieve his symptoms. On day 3 of admission, addiction medicine was consulted and his regimen was changed to diazepam 80 mg daily with additional as-needed diazepam based on etizolam equivalence. He also received a 5-day methadone taper with plans to transition to buprenorphine in the outpatient setting. Upon discharge he was referred to an addiction medicine specialist who was willing to continue a slow diazepam taper and initiate medications for opioid use disorder to manage both substance use disorders. Discussion This case report demonstrates the effectiveness of diazepam in managing benzodiazepine withdrawal from etizolam while concurrently using methadone to manage opioid withdrawal symptoms from tianeptine in a hospitalized patient following overdose. We highlight the importance of a warm handoff in considering the outpatient discharge plan.

Publisher

College of Psychiatric and Neurologic Pharmacists (CPNP)

Subject

Pharmacology (medical),Neurology (clinical),General Pharmacology, Toxicology and Pharmaceutics,Neuropsychology and Physiological Psychology

Reference17 articles.

1. Drug Enforcement Administration [Internet]. Drug and chemical evaluation section: etizolam [updated 2020 Mar; cited 2022 Sep 1]. Springfield (VA): US Department of Justice. Available from: https://www.deadiversion.usdoj.gov/drug_chem_info/etizolam.pdf

2. WHO Expert Committee on Drug Dependence [Internet]. Critical review report: etizolam [updated 2019 Oct 21-25; cited 2021 Sep 22]. Geneva: World Health Organization; c2019. Available from: https://www.who.int/medicines/access/controlled-substances/Final_Etizolam.pdf

3. Tamburin S, Mantovani E, Bertoldi A, Federico A, Casari R, Lugoboni F. High-dose dependence and cognitive side effects to medical prescription of etizolam. Front Psychiatry. 2020; 11: 601827. DOI: 10.3389/fpsyt.2020.601827. PubMed PMID: 33329156; PubMed Central PMCID: PMC7671959.

4. Levine M, Lovecchio F. New designer drugs. Emerg Med Clin North Am. 2021; 39(3): 677- 87. DOI: 10.1016/j.emc.2021.04.013. PubMed PMID: 34215409.

5. El Balkhi S, Monchaud C, Herault F, Géniaux H, Saint-Marcoux F. Designer benzodiazepines' pharmacological effects and potencies: how to find the information. J Psychopharmacol. 2020; 34(9): 1021- 9. DOI: 10.1177/0269881119901096. PubMed PMID: 31971477.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3